statistiche ricercatore

Continente	#
AS - Asia	522
NA - Nord America	441
EU - Europa	411
SA - Sud America	52
AF - Africa	13
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	1.441

Nazione	#
US - Stati Uniti d'America	425
SG - Singapore	222
RU - Federazione Russa	170
VN - Vietnam	99
IT - Italia	94
CN - Cina	87
BR - Brasile	39
HK - Hong Kong	33
FR - Francia	28
GB - Regno Unito	28
IN - India	24
DE - Germania	23
FI - Finlandia	18
BD - Bangladesh	16
UA - Ucraina	15
NL - Olanda	11
JP - Giappone	7
AR - Argentina	6
CA - Canada	6
MX - Messico	6
TH - Thailandia	6
CI - Costa d'Avorio	5
PK - Pakistan	5
ES - Italia	4
IQ - Iraq	4
KR - Corea	4
ZA - Sudafrica	4
AT - Austria	3
BE - Belgio	3
CH - Svizzera	3
EC - Ecuador	3
ID - Indonesia	3
PH - Filippine	3
PL - Polonia	3
BO - Bolivia	2
IE - Irlanda	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AU - Australia	1
AZ - Azerbaigian	1
BG - Bulgaria	1
CZ - Repubblica Ceca	1
EE - Estonia	1
EG - Egitto	1
GP - Guadalupe	1
HN - Honduras	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
KZ - Kazakistan	1
LT - Lituania	1
MY - Malesia	1
NI - Nicaragua	1
OM - Oman	1
SA - Arabia Saudita	1
SE - Svezia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SO - Somalia	1
TR - Turchia	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.441

Nome	#
Dyslipidemia in Transplant Patients: Which Therapy?	210
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study	141
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy	139
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies	135
Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women.	131
Treatment with pcsk9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet-activating factor and its precursors: A combined metabolomic and lipidomic approach	121
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy	117
An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with evolocumab	117
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study	116
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY	116
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY	114
Totale	1.457

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	87	0	4	2	0	2	1	1	5	3	11	45	13
2022/2023	102	9	6	6	8	10	15	1	14	17	8	6	2
2023/2024	107	11	8	4	7	7	26	0	6	14	3	5	16
2024/2025	382	25	9	6	11	6	36	39	30	16	34	150	20
2025/2026	756	70	40	85	71	154	27	93	26	90	54	13	33
2026/2027	7	7	0	0	0	0	0	0	0	0	0	0	0
Totale													1.457